Senti Biosciences Holdings, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
0.3770
-0.0005 (-0.13%)
At close: Aug 28, 2026, 4:00 PM EDT
0.3946
+0.0176 (4.67%)
After-hours: Aug 28, 2026, 7:59 PM EDT
SNTI Market Cap
SNTI has a market cap or net worth of $11.74 million as of August 28, 2026. Its market cap has decreased by -71.23% in one year.
Market Cap
11.74M
Enterprise Value
25.36M
1-Year Change
-71.23%
Ranking
Category
Stock Price
$0.38
ChartMarket Cap Chart
Since May 26, 2021, SNTI's market cap has decreased from $256.04M to $11.74M, a decrease of -95.41%. That is a compound annual growth rate of -44.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 11.74M | -57.06% |
| Dec 31, 2025 | 27.34M | 69.76% |
| Dec 31, 2024 | 16.11M | -45.22% |
| Dec 29, 2023 | 29.40M | -52.46% |
| Dec 30, 2022 | 61.84M | -78.72% |
| Dec 31, 2021 | 290.53M | 13.47% |
| May 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Moleculin Biotech | 12.66M |
| Quoin Pharmaceuticals | 12.29M |
| Aspire Biopharma Holdings | 11.94M |
| PDS Biotechnology | 11.80M |
| Kiora Pharmaceuticals | 11.59M |
| Theriva Biologics | 11.25M |
| Daré Bioscience | 11.24M |
| Vistagen Therapeutics | 11.22M |